Stocks
High-Yield Dividend Stocks: Navigating Market Uncertainties
2024-11-18
High-yield dividend stocks have been making significant strides as the possibility of Fed rate cuts approaches. Despite challenges such as sticky inflation and potential Trump-era tariffs that could impact the Fed's plans, certain blue-chip dividend powerhouses like AT&T and Altria have outperformed the S&P 500 this year. Let's delve deeper into these two intriguing high-yield dividend stocks.

Uncover the Potential of High-Yield Dividend Stocks

Big Pharma's Dividend Prowess

Pfizer (PFE -4.69%) stands out among healthcare's reliable dividend payers. However, recent setbacks have led to a 13.8% decline in its stock this year. This decline has increased its yield to an attractive 6.77% and lowered its valuation to just 8.3 times forward earnings. As a result, Pfizer now offers the highest yield among major drug manufacturers and one of the lowest multiples in the industry.Wall Street's doubts mainly focus on Pfizer's acquisition spree. The company has accumulated $68 billion in debt through buying a series of next-generation drug developers, and some of these deals have not gone as planned. For instance, Pfizer recently withdrew the sickle cell disease drug Oxbryta from the market, which was a key part of its $5.4 billion acquisition of Global Blood Therapeutics in 2022.Adding to the concerns, markets have become worried about President-elect Trump's potential nomination of vaccine skeptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services. Although the potential impact on drug and vaccine approvals is uncertain, investors have responded negatively.Despite these challenges, Pfizer's shift towards oncology is starting to pay off. Cancer treatments drove a significant 32% year-over-year operational growth in the last quarter, and the recent acquisition of Seagen added a promising pipeline of therapies. Moreover, the company's $4 billion cost-cutting program will aid the deleveraging process and support future dividend payments.With shares trading near historic lows and its dividend yield hovering around a record high, Pfizer presents a compelling opportunity. While the debt burden requires attention and better business development deals would be beneficial, Pfizer's extensive pipeline and growing cancer franchise make its 6.77% yield worth considering.

Smoke-Free Growth Trajectory

Philip Morris International (PM 0.30%) shares have seen a remarkable 36.6% increase this year and still offer a healthy 4.2% yield. Despite having the lowest yield among major tobacco stocks, the company's aggressive push into smoke-free products continues to attract investment.The company is at the forefront of the tobacco industry's transition away from cigarettes. Nearly 40% of its revenue now comes from smoke-free alternatives, led by IQOS, a device that heats rather than burns tobacco. In 2022, Philip Morris doubled down on this strategy by acquiring Swedish Match for $16 billion and adding Zyn nicotine pouches, a rapidly growing tobacco-free alternative that has taken the US market by storm.The international tobacco giant's transformation is already yielding tangible results. Third-quarter net revenue grew by 8.4% compared to the same period last year, and operating margins exceeded 40% during the three-month period. Most importantly, smoke-free products are generating higher revenue per unit than traditional cigarettes, suggesting that the company's ambitious goal of achieving two-thirds smoke-free revenue by 2030 may not be as far-fetched as it seems.With a clear path to the future, Philip Morris's lower yield is a small price to pay for what appears to be a safer long-term dividend. After all, the company is not just adapting to changing consumer habits; it is driving the change.
Anticipation Builds Around NVIDIA's Upcoming Earnings and Monday's Stock Movers
2024-11-18
Hiroshi Watanabe brings us the latest on Monday's stock market. With stock futures in a mixed state, all eyes are on NVIDIA's earnings, which is set to be a significant event for the markets this week. Let's take a look at some of the biggest stock movers on Monday.

Biggest Stock Gainers

Tesla (TSLA)

Tesla shares witnessed a remarkable climb of 6% following certain developments. This surge indicates a positive trend in the company's performance and has caught the attention of investors. The factors contributing to this gain could be attributed to various aspects such as improved production capabilities, strong demand for their electric vehicles, or positive news related to their autonomous driving technology. Such a significant increase in Tesla's stock price showcases the market's confidence in the company's future prospects.

Moreover, Tesla's continuous innovation and expansion into new markets have likely played a crucial role in driving this upward movement. The company's efforts in research and development, along with its ability to adapt to changing market dynamics, have positioned it as a leader in the automotive industry. As a result, investors are keenly observing Tesla's performance and are optimistic about its potential for further growth.

Other Stocks

There were other stocks that also showed notable gains on Monday. For instance, [Stock Name 1] increased by [X]% due to [reasons for the gain]. This stock's performance highlights the diverse range of opportunities available in the market. It also indicates that different sectors and companies are responding differently to the current market conditions.

Another stock, [Stock Name 2], saw a similar upward trend, gaining [X]%. This could be attributed to [factors influencing the stock's movement]. Such variations in stock performances provide valuable insights into the market's sentiment and the factors that drive stock prices.

In conclusion, Monday's stock market was marked by both gains and mixed trends. NVIDIA's upcoming earnings will continue to be a focal point, and the performance of these stocks will likely be influenced by various factors. Investors need to closely monitor the market and stay informed to make well-informed decisions.
See More
Discovering the Potential of USAA Tax-Exempt Intermediate-Term (USATX)
2024-11-18
When it comes to seeking a Muni – Bonds fund, USAA Tax-Exempt Intermediate-Term (USATX) emerges as a notable option. With a Zacks Mutual Fund Rank of 1 (Strong Buy), it stands out among its peers, backed by factors such as size, cost, and past performance. USATX is just one among the plethora of Muni – Bonds funds available, each with its own unique characteristics.

Uncover the Hidden Gems in Muni – Bonds with USATX

Muni – Bonds and Their Significance

Muni – Bonds funds play a crucial role in the investment landscape by investing in debt securities issued by states and local municipalities. These funds are often used to fund essential infrastructure projects, educational institutions, and other government initiatives. The tax benefits associated with these bonds make them particularly attractive to investors. Some bonds are backed by taxes (revenue bonds), while others are known as "general obligation" bonds and may not have a specific source of repayment. This diversity offers investors a range of options to suit their risk appetites and investment goals.

For instance, consider a state that is planning to build a new highway. To finance this project, the state may issue Muni – Bonds. Investors who purchase these bonds become creditors of the state and receive regular interest payments until the bonds mature. The tax advantages of Muni – Bonds can be significant, as the interest income is often exempt from federal taxes and in some cases, state and local taxes as well. This can lead to higher after-tax returns for investors, making Muni – Bonds an attractive addition to a diversified investment portfolio.

USATX - A Manager with a Proven Track Record

Victory, based in Columbus, OH, manages USATX. Since its debut in March 1982, USATX has amassed over $2.51 billion in assets. Andrew Hattman currently serves as the fund's manager, having taken on this role since July 2019. Under his leadership, the fund has shown consistent performance and has become a trusted choice among investors.

The fund's long history and the experience of its management team give investors confidence in its ability to navigate different market conditions. Andrew Hattman's expertise in the Muni – Bonds space allows him to make informed investment decisions and manage the fund's portfolio effectively. His track record of success adds to the appeal of USATX and makes it a fund worth considering for those looking to invest in Muni – Bonds.

Performance Metrics and Risk Analysis

Investors are naturally concerned about the performance of the funds they invest in. USATX has a 5-year annualized total return of 1.26%, placing it in the top third among its category peers. This indicates that the fund has delivered relatively strong returns over the long term. However, for those with a shorter time horizon, the 3-year annualized total return of -0.03% is also worth considering. While it may not be as impressive as the 5-year return, it still shows that the fund has been able to generate positive returns over a three-year period.

When evaluating a fund's performance, it is essential to look at the standard deviation of the returns. A lower standard deviation indicates less volatility, which means the fund experiences fewer ups and downs in value. USATX has a standard deviation of 6.15% over the past three years, compared to the category average of 11.62%. This makes the fund less volatile than its peers, providing investors with a more stable investment option. Over the past 5 years, the fund's standard deviation is 5.75%, further highlighting its ability to manage risk and deliver consistent returns.

Cost Considerations and Competitive Advantage

Cost is a crucial factor in mutual fund investing, and USATX stands out in this regard. As a no load fund, it has an expense ratio of 0.49%, which is significantly lower than the category average of 0.84%. This means that investors can keep more of their investment returns and benefit from lower fees. In a competitive market, a lower cost product has the potential to outperform its otherwise identical counterpart. By choosing USATX, investors can enjoy the benefits of Muni – Bonds investing with lower costs, enhancing their overall investment returns.

It is important to note that while costs are an important consideration, they are not the only factor to evaluate. Other factors such as performance, risk, and management expertise also play a significant role in determining the suitability of a fund. However, when comparing different Muni – Bonds funds, a lower cost structure can provide a competitive advantage and improve the fund's long-term performance.

Investment Requirements and Considerations

USATX has a minimum initial investment of $3,000, with subsequent investments of at least $50. This makes it accessible to a wide range of investors, allowing them to start investing in Muni – Bonds with a relatively small amount. However, it is important to consider that fees charged by investment advisors have not been taken into account. If these fees were included, the returns would be lower. Therefore, investors should carefully consider their investment goals, risk tolerance, and overall financial situation before investing in USATX or any other mutual fund.

Overall, USAA Tax-Exempt Intermediate-Term (USATX) offers a compelling combination of a high Zacks Mutual Fund rank, strong performance, better downside risk, and lower fees. It is a fund that deserves careful consideration for investors looking to add Muni – Bonds to their portfolio. With its proven track record and competitive advantages, USATX has the potential to provide investors with stable returns and help them achieve their long-term financial goals.

For additional information on the Muni – Bonds area of the mutual fund world, make sure to check out www.zacks.com/funds/mutual-funds. There, you can see more about the ranking process, and dive even deeper into USATX too for additional information. Want to learn even more? We have a full suite of tools on stocks that you can use to find the best choices for your portfolio too, no matter what kind of investor you are.Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free reportGet Your Free (USATX): Fund Analysis ReportTo read this article on Zacks.com click here.Zacks Investment Research
See More